Cargando…

In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β)

Alzheimer’s disease (AD) is caused by plaque agglomeration and entanglement in several areas of the neural cells, which leads to apoptosis. The main etiology of AD is senile dementia, which is linked to amyloid-beta (Aβ) deregulation and tau perivascular pathogeny. Hyperphosphorylated tau has a prop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goyal, Shuchi, Singh, Manjinder, Thirumal, Divya, Sharma, Pratibha, Mujwar, Somdutt, Mishra, Krishna Kumar, Singh, Thakur Gurjeet, Singh, Ravinder, Singh, Varinder, Singh, Tanveer, Ahmad, Sheikh F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604233/ https://www.ncbi.nlm.nih.gov/pubmed/37893156 http://dx.doi.org/10.3390/biomedicines11102784

Ejemplares similares

Scaffold Morphing and In Silico Design of Potential BACE-1 (β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics
por: Bhatia, Shiveena, et al.
Publicado: (2023)

Computational Studies to Understand the Neuroprotective Mechanism of Action Basil Compounds
por: Singh, Varinder, et al.
Publicado: (2023)

Recent Development of Novel Aminoethyl-Substituted Chalcones as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
por: Sharma, Pratibha, et al.
Publicado: (2023)

Expression of Glycogen synthase kinase 3-β (GSK3-β) gene in azoospermic men
por: Nazarian, Hamid, et al.
Publicado: (2014)

Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity
por: Gupte, Manisha, et al.
Publicado: (2020)

Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients
por: Maurya, Niharika, et al.
Publicado: (2019)

Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development
por: Bhatia, Shiveena, et al.
Publicado: (2022)

Phosphorylated Glycogen Synthase Kinase-3β (GSK-3β) Improves Cognition in Rats with Diabetes-Associated Cognitive Decline
por: Ke, Boxi, et al.
Publicado: (2019)

Glycogen Synthase Kinase 3β (GSK3β) Regulates Myogenic Differentiation in Skeletal Muscle Satellite Cells of Sheep
por: Yang, Jingquan, et al.
Publicado: (2022)

Alternative Splicing of the Porcine Glycogen Synthase Kinase 3β (GSK-3β) Gene with Differential Expression Patterns and Regulatory Functions
por: Wang, Linjie, et al.
Publicado: (2012)

Retracted: Phosphorylated Glycogen Synthase Kinase-3β (GSK-3β) Improves Cognition in Rats with Diabetes-Associated Cognitive Decline
por: Ke, Boxi, et al.
Publicado: (2019)

Glycogen Synthase Kinase 3 Beta (GSK3β) Phosphorylates the RNAase III Enzyme Drosha at S300 and S302
por: Tang, Xiaoli, et al.
Publicado: (2011)

Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
por: Pandey, Mukesh K., et al.
Publicado: (2016)

Multiple Alternative Splicing and Differential Expression Pattern of the Glycogen Synthase Kinase-3β (GSK3β) Gene in Goat (Capra hircus)
por: Hou, Yuguo, et al.
Publicado: (2014)

The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker
por: Chen, Shuo, et al.
Publicado: (2016)

Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)

Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma
por: Tsai, Chia-Lung, et al.
Publicado: (2021)

Dysregulated levels of glycogen synthase kinase-3β (GSK-3β) and miR-135 in peripheral blood samples of cases with nephrotic syndrome
por: Ardalan, Mohammadreza, et al.
Publicado: (2020)

Glycogen synthase kinase 3β (GSK3β) and presenilin (PS) are key regulators of kinesin-1-mediated cargo motility within axons
por: Banerjee, Rupkatha, et al.
Publicado: (2023)

Diabetic Endothelial Cell Glycogen Synthase Kinase 3β Activation Induces VCAM1 Ectodomain Shedding
por: Brishti, Masuma Akter, et al.
Publicado: (2023)

Inhibition of Glycogen Synthase Kinase 3 (GSK3) Increases the Cytotoxicity of Enzastaurin
por: Rovedo, Mark, et al.
Publicado: (2011)

Regulation of Autophagy by the Glycogen Synthase Kinase-3 (GSK-3) Signaling Pathway
por: Pan, Hsuan-Yeh, et al.
Publicado: (2022)

Integrin-Linked Kinase Is a Functional Mn(2+)-Dependent Protein Kinase that Regulates Glycogen Synthase Kinase-3β (GSK-3β) Phosphorylation
por: Maydan, Mykola, et al.
Publicado: (2010)

A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy
por: Gong, Ke, et al.
Publicado: (2023)

Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication
por: Shapira, Tirosh, et al.
Publicado: (2022)

Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
por: Domoto, Takahiro, et al.
Publicado: (2020)

Potential involvement of glycogen synthase kinase (GSK)-3β in a rat model of multiple sclerosis: evidenced by lithium treatment
por: Ahn, Meejung, et al.
Publicado: (2017)

Inhibition of Glycogen Synthase Kinase-3β (GSK-3β) as potent therapeutic strategy to ameliorates L-dopa-induced dyskinesia in 6-OHDA parkinsonian rats
por: Xie, Cheng-long, et al.
Publicado: (2016)

Involvement of Glycogen Synthase Kinase 3β (GSK3β) in Formation of Phosphorylated Tau and Death of Retinal Ganglion Cells of Rats Caused by Optic Nerve Crush
por: Fukiyama, Yurie, et al.
Publicado: (2023)

Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation
por: Amaral, Ana Claudia, et al.
Publicado: (2021)

Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease
por: Kaur, Rupinder, et al.
Publicado: (2023)

Repulsive Axon Guidance by Draxin Is Mediated by Protein Kinase B (Akt), Glycogen Synthase Kinase-3β (GSK-3β) and Microtubule-Associated Protein 1B
por: Meli, Rajeshwari, et al.
Publicado: (2015)

Xeroderma Pigmentosum Group D (XPD) Inhibits the Proliferation Cycle of Vascular Smooth Muscle Cell (VSMC) by Activating Glycogen Synthase Kinase 3β (GSK3β)
por: Li, Qing, et al.
Publicado: (2018)

Glycogen Synthase Kinase-3 (GSK-3) Regulation of Inhibitory Coreceptor Expression in T-cell Immunity
por: Issa, Mark E., et al.
Publicado: (2021)

Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)
por: LI, DA-WEI, et al.
Publicado: (2014)

Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
por: Shimasaki, Takeo, et al.
Publicado: (2012)

Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD
por: Ngkelo, Anta, et al.
Publicado: (2015)

Glycogen synthase kinase 3β in Toll-like receptor signaling
por: Ko, Ryeojin, et al.
Publicado: (2016)

Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors
por: Hulcová, Daniela, et al.
Publicado: (2018)

The association of glycogen synthase kinase-3beta (GSK-3β) gene polymorphism with kidney function in long-term lithium-treated bipolar patients
por: Rybakowski, Janusz K, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l4tpc11c2q6tibir5cjohfs3f2